Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. - Wikidata - awgldk - TriplyDB

Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.

Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.

http://www.wikidata.org/entity/Q34332841

about

Current clinical immunotherapeutic approaches for head and neck cancer Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approaches Human papillomavirus induced transformation in cervical and head and neck cancers Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.Current Role of Surgery in the Management of Oropharyngeal Cancer Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma Novel targets in head and neck cancer: should we be optimistic?Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.Stereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking history.Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas.Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma.Integrated analysis of oral tongue squamous cell carcinoma identifies key variants and pathways linked to risk habits, HPV, clinical parameters and tumor recurrence.Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines Evaluating the potential role of PET/CT in the posttreatment surveillance of head and neck cancer Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients.Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients.Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.Emerging biomarkers in head and neck cancer in the era of genomics.Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.A novel functional splice variant of AKT3 defined by analysis of alternative splice expression in HPV-positive oropharyngeal cancers.Oropharyngeal cancer and human papilloma virus: evolving diagnostic and management paradigms.The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy.Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.Survival outcomes following salvage surgery for oropharyngeal squamous cell carcinoma: systematic review.Safety of drug treatments for head and neck cancer.Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC.

P2860

Q26745411-3802E210-EA33-46BE-9E58-5D5DAF70443A Q26767046-D6C07787-8EEA-4EDE-9310-F54595955694 Q27003141-4FF28B8B-DD23-4090-9452-78589A8CD793 Q30251868-2000F451-4A30-4DA3-976B-76BA306869D9 Q30373904-7148E3DC-AB00-49EB-A12A-D8C3745EE0F8 Q33652572-05A5C380-E2B6-4CB0-8E6E-737E3F02A825 Q33854472-E24443B1-684E-42CF-AE80-F56C094A0EDF Q35048213-AC6889EB-4E34-4BEF-8B59-31A351A69D92 Q35688621-957F9B21-6C20-4F53-9379-4D88B65684EA Q35693308-00210F1A-BFF7-4188-B5FA-E846FA65F615 Q35750840-A6446B8B-A072-41FA-A1B3-95D60AB6CDBF Q35861606-9839DEC5-ED28-45B6-B4CF-D5EF2B715974 Q35892011-1E5C846C-0BD2-422E-ADDC-3F0F9C2CCF73 Q36000879-C919188B-AE64-4905-9B08-F73FD0DCC9BF Q36405555-8FB15DE6-3C88-49B2-95D3-D62D93B07C8B Q36444471-1E70A7C6-DFD2-4947-B1C2-B40297E6C82E Q36655507-A664B8D7-CACE-4ED2-9C03-2DD8B24DB828 Q36737621-33360033-B599-49B9-A743-D29652AEF8D8 Q36838932-6937B90C-E8D8-4E75-8E6D-D2E5E5E28CEA Q36919591-C2165B49-35D1-4157-A41D-BDDAE93F9A90 Q37146255-3DFB8438-A16D-43AE-8D18-D703CF2AFCC7 Q37170267-A4E60F50-8F59-4C07-BADA-6277D732298E Q37199243-77F1DD69-B3B2-48E2-9887-8CC25B7034E1 Q37364313-F15B44BC-B240-4C27-9F02-F029CA44C6E9 Q37687705-5C7421A7-CBD5-4BEF-8776-EEEC18711C46 Q38252802-47FD87DF-5CB2-4D00-88AB-E5850C96B1F8 Q38268896-448EF4A4-F755-40E1-AD35-BC8A81653830 Q38583292-86FC3C89-0FEF-4D22-8362-3D0EC90AFE2F Q38620191-708DFC99-DC38-4F51-AA15-88C01082B98E Q38632754-70DC3B47-8783-417B-8BF8-69A4A9C1A415 Q38650589-997B47E8-BF6C-4F66-B3B1-D6E50D798193 Q38667225-BFF734A1-605A-4BEE-8E6C-2CE2D3EBDE4C Q38674531-A7C5C47E-6210-45E3-BD91-9102F9A52AD0 Q38723059-25574920-DC35-4D0D-8EE3-87B564553BF3 Q38747543-A3A51200-E2AA-4D6F-BFFA-41B8ED8B65A6 Q38764833-C2E83346-2FA8-4C0C-B3B2-C14B2465A11A Q38787254-6918CA17-F741-4ABF-8116-1C5A5867FD64 Q38809582-12FB2A47-E967-49BF-9382-369C2B98D270 Q38816144-4B15BDFD-A7FB-456E-9DDA-25113013AC05 Q38818008-19F96A0B-982A-4D33-82EE-0E82FEB5BA0F

P2860

Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.

http://www.wikidata.org/entity/Q34332841

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@ast

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@en

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@nl

type

label

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@ast

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@en

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@nl

prefLabel

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@ast

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@en

Human papillomavirus and overa ...... ngeal squamous cell carcinoma.

@nl

P1433

Q34332841-2D5B6AFF-0333-4562-88CB-68B10CE51BDC

P1476

Q34332841-D0C53DC5-5445-4328-BA7C-11C626174BEB

P2093

Q34332841-1DA87D2F-537F-4C87-AE56-6C43DB5A7609

Q34332841-205DE959-230D-4134-BB97-E8875A298DBD

Q34332841-73BE7C6B-79EB-4D69-8FEF-37C73B8653C9

Q34332841-95E73371-0E95-447A-A9D6-EB0A0E562477

Q34332841-9C9D39DB-E2DD-42CD-9EFD-BF9D62A3FA73

Q34332841-B774145A-A4CB-461D-93E8-2C995D25F7FA

Q34332841-B828A413-C4C8-4D17-94A8-AE6373BE03DA

Q34332841-CEC9C895-F771-45F3-BE39-854C4CB1B3B2

Q34332841-D8889BEC-5BF2-4950-8D1E-D53DD024DA75

Q34332841-E2C08B48-F629-40E3-8D8B-6DB7B8D46453

P2860

Q34332841-10979664-FE65-4300-B2CC-340304B5A10E

Q34332841-14F534B9-FE59-4854-8890-78F3032037F5

Q34332841-15E62BA8-BBC6-4A0C-BC4D-C7B79AAFC24C

Q34332841-1CE969CB-DD49-4C1B-8C89-4972B073E737

Q34332841-235944A5-0549-4322-A7A5-581227080577

Q34332841-2786A8B4-B8D3-47CE-AF8B-67EEE5FE09DC

Q34332841-2AA65A89-4DF0-4683-87BF-EA1C444324F0

Q34332841-3222308D-E19F-4FAD-89CB-2CB874826194

Q34332841-432AE8E8-9A24-4A88-B80F-D6602786CC6F

Q34332841-48209B69-C0E1-46F5-B28C-C0C6B1ADC4B0

P304

Q34332841-488F3A35-5D87-4E14-8E43-430ED3F61738

P31

Q34332841-7936DEDC-7142-4AB4-B7FE-43462633F6CB

P356

Q34332841-5F897A7C-DF53-4287-BA9F-2F312EA457EB

P407

Q34332841-327C48BD-EDE7-4C36-93DC-9477FA5D5204

P433

Q34332841-A7B6D573-985D-4B86-A22C-9083C34C72D6

P478

Q34332841-0BCAC32F-9186-4726-94E2-35D1970E2395

P50

Q34332841-6AFF42D4-535A-40F5-9C6E-CA0C1A4B478B

P577

Q34332841-58998D20-866F-41FF-86AB-9A64776256A2

P698

Q34332841-6BD0DBA1-FC19-4B99-8CE4-2CCB5F0A1181

P932

Q34332841-89A2EC43-DE96-4AF9-9EA5-47E5143E01D8

P356

JCO.2014.55.1937

P1433

Journal of Clinical Oncology

P1476

Human papillomavirus and overa ...... yngeal squamous cell carcinoma

@en

P2093

Adam S Garden

http://www.w3.org/2001/XMLSchema#string

Adel El-Naggar

http://www.w3.org/2001/XMLSchema#string

Andy Trotti

http://www.w3.org/2001/XMLSchema#string

Carole Fakhry

http://www.w3.org/2001/XMLSchema#string

Denis Soulieres

http://www.w3.org/2001/XMLSchema#string

John Andrew Ridge

http://www.w3.org/2001/XMLSchema#string

Jonathan Harris

http://www.w3.org/2001/XMLSchema#string

Maura Gillison

http://www.w3.org/2001/XMLSchema#string

Phuc Felix Nguyen-Tan

http://www.w3.org/2001/XMLSchema#string

Qiang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review

Human papillomavirus and survival of patients with oropharyngeal cancer.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study.

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.

Evaluation of survival data and two new rank order statistics arising in its consideration.

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.

P304

3365-3373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2014.55.1937

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

David I Rosenthal

P577

2014-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24958820

http://www.w3.org/2001/XMLSchema#string

P932

4195851

http://www.w3.org/2001/XMLSchema#string